{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:46Z","timestamp":1789726246270,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpurol.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T22:35:47Z","timestamp":1597790147000},"page":"65.e1-65.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-1830","authenticated-orcid":false,"given":"Mahmoud Marei","family":"Marei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raef","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.B.","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2020.08.007_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2015.00045","article-title":"Epidemiology and characteristics of urinary tract infections in children and adolescents","volume":"5","author":"Hanna-Wakim","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2014.11.007","article-title":"Urinary tract infections in children: EAU\/ESPU guidelines","volume":"67","author":"Stein","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2020.08.007_bib3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2982","article-title":"Recurrent urinary tract infections in children with bladder and bowel dysfunction","volume":"137","author":"Shaikh","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpurol.2020.08.007_bib4","unstructured":"Urinary tract infection in under 16s: diagnosis and management | NICE Guidance | NICE Clinical guideline [CG54] | https:\/\/www.nice.org.uk\/guidance\/cg54."},{"key":"10.1016\/j.jpurol.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11934-018-0834-8","article-title":"Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review","volume":"19","author":"Pietropaolo","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.jpurol.2020.08.007_bib6","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0022-5347(05)00928-6","article-title":"Safety of gentamicin bladder irrigations in complex urological cases","volume":"175","author":"Defoor","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.jpurol.2018.12.001","article-title":"Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization","volume":"15","author":"Huen","year":"2019","journal-title":"J Pediatr Urol"},{"issue":"9","key":"10.1016\/j.jpurol.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"E350","DOI":"10.5489\/cuaj.4434","article-title":"Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization","volume":"11","author":"Cox","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.jpurol.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-5347(17)44085-7","article-title":"Treatment of intractable bacterial cystitis with intermittent catheterization and antimicrobial instillation: case report","volume":"137","author":"McGuire","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/01.ju.0000137938.47097.63","article-title":"Absorption OF intravesically applied drugs: comparison OF normal and ileal augmented rabbit bladder","volume":"172","author":"Krege","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0090-4295(94)90249-6","article-title":"Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies","volume":"43","author":"Wan","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-199937010-00004","article-title":"Intravesical drug delivery. Pharmacokinetic and clinical considerations","volume":"37","author":"Highley","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpurol.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0090-4295(86)90372-9","article-title":"Absorption of anticancer drugs through bladder epithelium","volume":"27","author":"Mishina","year":"1986","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2020.08.007_bib14","first-page":"127","article-title":"Factors influencing the absorption of antineoplastic agents in intravesical instillation treatment of bladder tumors. An experimental and clinical study","volume":"100","author":"Gu","year":"1987","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jpurol.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1464-410x.2001.02227.x","article-title":"Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor","volume":"87","author":"Lose","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2020.08.007_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3109\/00365528608996449","article-title":"Ultrastructural and histochemical changes in ileal reservoir mucosa after long-term exposure to urine: a study in patients with continent urostomy (kock pouch)","volume":"21","author":"Philipson","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000281675","article-title":"Histological and scanning electron microscopic alterations in heal conduit depending on the time factor","volume":"45","author":"Hanke","year":"1990","journal-title":"Urol Int"},{"key":"10.1016\/j.jpurol.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0022-5347(17)40001-2","article-title":"Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug","volume":"143","author":"Foss\u00e5","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-5347(17)35725-7","article-title":"Neomycin toxicity in bladder irrigation","volume":"150","author":"de Jong","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib20","first-page":"121","article-title":"Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions","volume":"9","author":"Pannek","year":"2017","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.jpurol.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5489\/cuaj.337","article-title":"Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: the Alberta context","volume":"7","author":"Hill","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.jpurol.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00256954","article-title":"Effect of D-mannose and D-glucose on Escherichia coli bacteriuria in rats","volume":"11","author":"Michaels","year":"1983","journal-title":"Urol Res"},{"key":"10.1016\/j.jpurol.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00192-017-3508-z","article-title":"Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis","volume":"29","author":"Goddard","year":"2018","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jpurol.2020.08.007_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009669","article-title":"Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study","volume":"6","author":"Ciani","year":"2016","journal-title":"BMJ Open"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120304964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513120304964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:49:33Z","timestamp":1761486573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513120304964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1477513120304964"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.08.007","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}